Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07508241

A Study to Learn About the Effect of Study Medicine Called PF-08653944 on How Quickly the Stomach Empties Its Content in Healthy Adults With Overweight or Obesity

A PHASE 1, OPEN-LABEL, MULTIPLE DOSE STUDY TO INVESTIGATE THE IMPACT OF PF 08653944 ON GASTRIC EMPTYING IN ADULT PARTICIPANTS WITH OVERWEIGHT OR OBESITY

Status
Not Yet Recruiting
Phase
Phase 1
Study type
Interventional
Enrollment
20 (estimated)
Sponsor
Pfizer · Industry
Sex
All
Age
18 Years – 99 Years
Healthy volunteers
Accepted

Summary

This study looks at how a study medicine called PF-08653944 affects how quickly the stomach empties food after eating. It is being done in adults who are overweight or have obesity. Participants will receive the study medicine for a short period, and doctors will measure how the medicine moves through the stomach and monitor safety. The goal is to better understand how this medicine works in the body and to check for any side effects. The information from this study may help researchers plan future studies of this medicine.

Conditions

Interventions

TypeNameDescription
DRUGPF-08653944Subcutaneous Injection
DRUGAcetaminophenOral suspension

Timeline

Start date
2026-03-31
Primary completion
2027-01-27
Completion
2027-01-27
First posted
2026-04-02
Last updated
2026-04-02

Regulatory

Source: ClinicalTrials.gov record NCT07508241. Inclusion in this directory is not an endorsement.